{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:49:19Z","timestamp":1785552559697,"version":"3.56.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/PSI-GER\/28076\/2017"],"award-info":[{"award-number":["PTDC\/PSI-GER\/28076\/2017"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["PTDC\/PSI-GER\/28076\/2017"],"award-info":[{"award-number":["PTDC\/PSI-GER\/28076\/2017"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.lfs.2021.119182","type":"journal-article","created":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T13:03:47Z","timestamp":1612875827000},"page":"119182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Concise perspectives on some synthetic thiazolidine-2,4-dione derivatives and their specific pharmacodynamic aspects"],"prefix":"10.1016","volume":"271","author":[{"given":"Srinivasa R.","family":"Vulichi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Kabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupak","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kapur","family":"Suman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunduri Venkata","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nat\u00e1lia","family":"Cruz-Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2021.119182_bb0005","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nature05482","article-title":"Mechanisms linking obesity to insulin resistance and type 2 diabetes","volume":"444","author":"Kahn","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2021.119182_bb0010","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2337\/diab.41.6.715","article-title":"Prospective analysis of insulin resistance syndrome","volume":"41","author":"Haffner","year":"1992","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2021.119182_bb0015","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1089\/met.2009.0024","article-title":"The metabolic syndrome in South Asians: epidemiology, determinants and prevention","volume":"7","author":"Misra","year":"2009","journal-title":"Metab. Syndr. Relat. Disord."},{"issue":"4","key":"10.1016\/j.lfs.2021.119182_bb0020","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2174\/1567201811666140118225021","article-title":"Recent advances in drug delivery systems for anti-diabetic drugs: a review","volume":"11","author":"Grover","year":"2014","journal-title":"Curr. Drug Deliv."},{"issue":"12","key":"10.1016\/j.lfs.2021.119182_bb0025","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.phymed.2009.05.021","article-title":"Synergistic effect of phytochemicals in combination with hypoglycemic drugs on glucose uptake in myotubes","volume":"16","author":"Prabhakar","year":"2009","journal-title":"Phytomedicine"},{"issue":"14","key":"10.1016\/j.lfs.2021.119182_bb0030","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.2174\/1389450119666180621093833","article-title":"Treatment of \u2018diabesity\u2019: beyond pharmacotherapy","volume":"19","author":"Singh","year":"2018","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.lfs.2021.119182_bb0035","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jare.2020.01.008","article-title":"An overview on medicinal perspective of thiazolidine-2,4-dione: a remarkable scaffold in the treatment of type 2 diabetes","volume":"23","author":"Bansala","year":"2020","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.lfs.2021.119182_bb0040","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41598-017-18274-1","article-title":"Structural basis for enhanced anti-diabetic efficacy of lobeglitazone on PPAR-\u03b3","volume":"8","author":"Jang","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2021.119182_bb0045","first-page":"9","article-title":"Efficacy and safety of lobeglitazone monotherapy in patients with type 2 diabetes mellitus over 24-weeks: a multicenter, randomized, double-blind, parallel-group, placebo-controlled trial","volume":"e92843","author":"Kim","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2021.119182_bb0050","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bioorg.2017.11.010","article-title":"Design, synthesis and molecular docking of thiazolidinedione based benzene sulphonamide derivatives containing pyrazole core as potential anti-diabetic agents","volume":"76","author":"Naim","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.lfs.2021.119182_bb0055","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ejmech.2017.11.041","article-title":"Aegeline inspired synthesis of novel amino alcohol and thiazolidinedione hybrids with anti-adipogenic activity in 3T3-L1 cells","volume":"143","author":"Satish","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.lfs.2021.119182_bb0060","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1055\/a-0851-6879","article-title":"Pharmacokinetics and tissue distribution of aegeline after oral administration in mice","volume":"85","author":"Manda","year":"2019","journal-title":"Planta Med."},{"key":"10.1016\/j.lfs.2021.119182_bb0065","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17082-x","article-title":"Structures of PPAR-\u03b3 complexed with lobeglitazone and pioglitazone reveal key determinants for the recognition of antidiabetic drugs","volume":"7","author":"Lee","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2021.119182_bb0070","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bioorg.2017.05.007","article-title":"Synthesis, molecular docking and anti-diabetic evaluation of 2,4-thiazolidinedione based amide derivatives","volume":"73","author":"Naim","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.lfs.2021.119182_bb0075","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14776-0","article-title":"Novel benzylidene thiazolidinedione derivatives as partial PPAR-\u03b3 agonists and their anti-diabetic effects on Type 2 diabetes","volume":"7","author":"Yasmin","year":"2017","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.lfs.2021.119182_bb0080","doi-asserted-by":"crossref","DOI":"10.4172\/2161-0444.1000409","article-title":"Microwave assisted synthesis and anti-diabetic activity of novel 5-[4-(substituted) benzylidene]-thiazolidine-2,4-dione","volume":"6","author":"Patel","year":"2016","journal-title":"Med. Chem. (Los Angeles)"},{"issue":"10","key":"10.1016\/j.lfs.2021.119182_bb0085","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1007\/s00044-016-1675-y","article-title":"Design, synthesis and evaluation of novel thiazolidinedione derivatives as anti-hyperglycemic and anti-hyperlipidemic agents","volume":"25","author":"Shrivastava","year":"2016","journal-title":"Med. Chem. Res."},{"issue":"33","key":"10.1016\/j.lfs.2021.119182_bb0090","doi-asserted-by":"crossref","first-page":"28169","DOI":"10.1074\/jbc.M111.332106","article-title":"GQ-16, a novel peroxisome proliferator- activated receptor (PPAR) ligand, promotes insulin sensitization without weight gain","volume":"287","author":"Amato","year":"2012","journal-title":"J. Biol. Chem."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521001673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521001673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:44:55Z","timestamp":1758401095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320521001673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":18,"alternative-id":["S0024320521001673"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119182","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concise perspectives on some synthetic thiazolidine-2,4-dione derivatives and their specific pharmacodynamic aspects","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119182","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"119182"}}